Last updated on March 2018

The Combination Therapy With Ra-223 and Enzalutamide


Brief description of study

This study is to evaluate preliminary efficacy of Ra-223 in combination with Enzalutamide in progressive CRPC patients with bone metastasis

Clinical Study Identifier: NCT03305224

Contact Investigators or Research Sites near you

Start Over

Taro Iguchi, MD, PhD

Osaka City University Graduate School of Medicine
Osaka, Japan
  Connect »